Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The trials included in the model were all global trials, with the exception of the Japanese trial
While CNIPA declared the patent invalid in September 2022, it was later upheld by the Beijing IP court in light of the post-filing data submitted by Novo Nordisk establishing that the written disclosure supports the hypothesis that semaglutide has a longer half-life and duration of action versus the prior art
Yan Y, et al
6 x 10 mg vials covers it
US$ 27.44
US$ 27.82
US$ 23.71
